Evidence map›Paper›PMID 36731754›Full record

ArticlePreventive medicine2023

The first nicotine product tried is associated with current multiple nicotine product use and nicotine dependence among a nationally representative sample of U.S. youths.

Patricia Simon, Eugenia Buta, Asti Jackson, Deepa R Camenga, Grace Kong, Meghan E Morean, Krysten W Bold, Danielle R Davis, Suchitra Krishnan-Sarin, Ralitza Gueorguieva

Open access · greenAbstract read
In one paragraph

Article in Preventive medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. What is the Addictive Potential from Vaping?Nordisk alkohol- & narkotikatidskrift : NAT · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Patricia SimonDepartment of Psychiatry, Yale University School of Medicine, 389 Whitney Avenue, New Haven, CT 06515, USA. Electronic address: p.simon@yale.edu.
Eugenia ButaDepartment of Biostatistics, Yale School of Public Health, 300 George Street, Ste 555, New Haven, CT 06511, USA.
Asti JacksonDepartment of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA.
Deepa R CamengaDepartment of Emergency Medicine, Yale University School of Medicine, 464 Congress Avenue Suite 260, New Haven, CT 06519, USA.
Grace KongDepartment of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA.
Meghan E MoreanDepartment of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA.
Krysten W BoldDepartment of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA.
Danielle R DavisDepartment of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA.
Suchitra Krishnan-SarinDepartment of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA.
Ralitza GueorguievaDepartment of Biostatistics, Yale School of Public Health, P.O. Box 208034, 60 College Street, New Haven, CT 06520, USA.
Yale University · USWhitney Museum of American Art · US

Funding

Yale Center for the Study of Tobacco Product Use and Addiction (YCSTP) Project 2: Addictive Threshold of Nicotine and the Impact of SweetenersU54DA036151 · NIDA · YALE UNIVERSITY · PI Nii A Addy · 2018 to 2026
$41.6M
An Examination of Polytobacco Use Trajectories and Socioecological Risk FactorsR03CA245991 · NCI · YALE UNIVERSITY · PI SIMON, PATRICIA · 2020 to 2021
$168k
NCI NIH HHS R03 CA245991NIDA NIH HHS L40 DA042454NIDA NIH HHS U54 DA036151
6 · The paper itself

Abstract

This study examines the demographic factors associated with youths' first product tried (i.e., cigarettes, e-cigarettes, cigars, hookah, or smokeless tobacco). This study also evaluates whether the first product tried is associated with future nicotine product use (i.e., no use, single product use, and multiple product use) and nicotine dependence. Participants were 1999 youths (ages 12-17 years) who had ever tried a nicotine product and completed the Population Assessment of Tobacco Health study's Wave 1 (2013-2014) and Wave 4 (2016-2018) assessments. Two separate multinomial logistic regression models examined the association between 1) demographic factors and the first product tried at Wave 1 and 2) the first product tried at Wave 1 and past-30-day product use status at Wave 4. A two-part multivariable model examined the association between the first product tried and nicotine dependence, with part 1 modeling the presence (or absence) of any symptom of dependence and part 2 modeling the degree of dependence among those with any symptom of dependence. The first product tried was associated with sex, race, urbanicity, and parent education. First trying smokeless tobacco (vs. e-cigarettes) was associated with a greater likelihood of multiple product use (vs. no use and vs. single product use). Regarding the degree of nicotine dependence (n = 713), first trying smokeless tobacco (vs. e-cigarettes) was associated with higher nicotine dependence scores among those with any symptom of dependence. Youths who first try smokeless tobacco (vs. e-cigarettes) may be at higher risk for future multiple product use and more symptoms nicotine dependence. Research should explore tailored interventions for smokeless tobacco users.

Indexed as

Electronic Nicotine Delivery SystemsTobacco ProductsTobacco Use DisorderAdolescentChildHumansNicotineTobacco UseUnited StatesNicotineAdolescentsE-cigarettesMultiple nicotine product useNicotine dependencePolytobacco useSmoking devicesTobacco

Identifiers

PMID36731754
PMCPMC10507373
OpenAlexW4318465022

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.